专利检索 ap:("Rigel Pharmaceuticals, Inc.") AND inv:"CHAN, Eva" 第 1 页

1.

发明公开
TANKYRASE H, COMPOSITIONS INVOLVED IN THE CELL CYCLE AND METHODS OF USE 审中-公开
标题翻译：端锚聚合酶为h，它与细胞周期是否涉及组合物及其用途

公开(公告)号：EP1238063A2

公开(公告)日：2002-09-11

申请号：EP00988503.9

申请日：2000-10-25

申请人： Rigel Pharmaceuticals, Inc.

发明人： LUO, Ying , CHAN, Eva , XU, Xiang , HUANG, Betty , OSSOVSKAYA, Valeria

IPC分类号： C12N9/10 , C12N15/54 , C07K16/40 , A61K38/45 , C12Q1/68 , C12Q1/48 , G01N33/50

CPC分类号： C12N9/1077 , A61K38/00 , C12N2310/111

摘要： The present invention is directed to novel polypeptides, nucleic acids and related molecules which have an effect on or are related to the cell cycle. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention. Further provided by the present invention are methods for identifying novel compositions which mediate cell cycle bioactivity, and the use of such compositions in diagnosis and treatment of disease.

2.

发明公开
CHECKPOINT GENE ASSOCIATED CELL CYCLE PROTEINS, COMPOSITIONS AND METHODS OF USE 审中-公开
标题翻译：与细胞周期蛋白耦合控制基因，及其组合物及其应用

公开(公告)号：EP1218520A1

公开(公告)日：2002-07-03

申请号：EP00965361.9

申请日：2000-09-22

申请人： Rigel Pharmaceuticals, Inc.

发明人： LUO, Ying , CHAN, Eva

IPC分类号： C12N15/61 , C12N9/90 , C12Q1/533 , C07K16/40

CPC分类号： C12N9/90

摘要： The present invention is directed to novel polypeptides, nucleic acids and related molecules which have an effect on or are related to the cell cycle. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention. Further provided by the present invention are methods for identifying novel compositions which mediate cell cycle bioactivity, and the use of such compositions in diagnosis and treatment of disease.